Cytomegalovirus prevention in high-risk lung transplant recipients: comparison of 3- vs 12-month valganciclovir therapy. (Q45949632)
Jump to navigation
Jump to search
scientific article published on 13 May 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Cytomegalovirus prevention in high-risk lung transplant recipients: comparison of 3- vs 12-month valganciclovir therapy. |
scientific article published on 13 May 2009 |
Statements
Cytomegalovirus prevention in high-risk lung transplant recipients: comparison of 3- vs 12-month valganciclovir therapy (English)
Walter Klepetko
Peter Jaksch
Barbara Zweytick
Ali Mir Hoda
Maya Keplinger